Stifel Financial’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-53,316
| Closed | -$2.41M | – | 3204 |
|
|
2020
Q4 | $2.41M | Sell |
53,316
-887
| -2% | -$40.1K | ﹤0.01% | 1275 |
|
|
2020
Q3 | $1.92M | Sell |
54,203
-1,453
| -3% | -$51.4K | ﹤0.01% | 1234 |
|
|
2020
Q2 | $2.1M | Sell |
55,656
-761
| -1% | -$28.7K | ﹤0.01% | 1126 |
|
|
2020
Q1 | $1.65M | Sell |
56,417
-19,725
| -26% | -$576K | ﹤0.01% | 1143 |
|
|
2019
Q4 | $3.96M | Sell |
76,142
-17,133
| -18% | -$890K | 0.01% | 983 |
|
|
2019
Q3 | $5.11M | Sell |
93,275
-5,345
| -5% | -$293K | 0.01% | 818 |
|
|
2019
Q2 | $4.01M | Buy |
98,620
+44,510
| +82% | +$1.81M | 0.01% | 953 |
|
|
2019
Q1 | $1.64M | Buy |
54,110
+5,035
| +10% | +$153K | ﹤0.01% | 1356 |
|
|
2018
Q4 | $1.65M | Sell |
49,075
-286
| -0.6% | -$9.61K | 0.01% | 1255 |
|
|
2018
Q3 | $2.09M | Sell |
49,361
-144,806
| -75% | -$6.14M | 0.01% | 1241 |
|
|
2018
Q2 | $6.17M | Sell |
194,167
-64,709
| -25% | -$2.05M | 0.02% | 717 |
|
|
2018
Q1 | $12.9M | Buy |
258,876
+74,311
| +40% | +$3.7M | 0.04% | 437 |
|
|
2017
Q4 | $9.96M | Buy |
184,565
+4,998
| +3% | +$270K | 0.03% | 530 |
|
|
2017
Q3 | $10.5M | Buy |
179,567
+15,873
| +10% | +$924K | 0.04% | 491 |
|
|
2017
Q2 | $8.08M | Buy |
163,694
+22,990
| +16% | +$1.13M | 0.03% | 557 |
|
|
2017
Q1 | $6.12M | Buy |
140,704
+127,109
| +935% | +$5.53M | 0.02% | 624 |
|
|
2016
Q4 | $662K | Buy |
13,595
+2,178
| +19% | +$106K | ﹤0.01% | 1620 |
|
|
2016
Q3 | $548K | Buy |
11,417
+605
| +6% | +$29K | ﹤0.01% | 1680 |
|
|
2016
Q2 | $581K | Buy |
10,812
+520
| +5% | +$27.9K | ﹤0.01% | 1671 |
|
|
2016
Q1 | $461K | Buy |
10,292
+1,343
| +15% | +$60.2K | ﹤0.01% | 1624 |
|
|
2015
Q4 | $341K | Buy |
8,949
+544
| +6% | +$20.7K | ﹤0.01% | 1842 |
|
|
2015
Q3 | $267K | Buy |
+8,405
| New | +$267K | ﹤0.01% | 1879 |
|